Schering vs. Roche
What I find most significant about this report is that genotype 1 patients got somewhere between a 48% and 54%... View Article
Continue reading »Research & Treatment News
Share
Follow Us
Steatosis and Fibrosis
May 16, 2005
1 Comment
Reading selectively in this article gives us this tidbit: "Age, ADD, diabetes and increase of ALT seem to be the only independent factors associated with liver fibrosis progression.” Among other things, this demonstrates the importance of keeping ALT levels as reduced as possible.
Continue reading »Small Molecule Drugs Are Coming for HCV
The following appeared in "Pharmaceutical Business Review Online". While this is just a short blurb, it is quite informative. The prediction for two more effective drugs to be launced in the next six or seven years is very, very encouraging.
Continue reading »Breakthrough HCV Therapy?
Vertex has been getting press on VX-950 for some time. Early tests were good which led to this Phase 1b study. If all remains well with this drug it could be a major step forward in the process of treating Hepatitis c. Stay tuned...
Continue reading »Phase 1 Trial of Tarvacin
Another experimental anti HCV drug in the pipeline! The more companies working on a solution, the greater the odds of a practical treatment for HCV genotype 1.
Continue reading »Milk Thistle Doses Studied Are Too Low
This study of previous studies showed inconclusive results for milk thistle preventing death from liver disease. However, the researchers conclude... View Article
Continue reading »Specific Genes Predict HCV Treatment Success
Wow! Now this is a great discovery. Imagine being able to know in advance if you can be helped by interferon combination therapy. You would not need to go through any discomfort to discover whether or not it would be effective for you.
Continue reading »Primary Concerns of HCV Patients
As researchers learn more about what issues are of most importance to patients they will be able to provide more relevant information and support.
Continue reading »Fibrotest vs. Biopsy
While primarily about Hyperlipidemia, this article verifies that FibroTest has been validated in chronic Hepatitis c. So, why are doctors still using biopsies???
Continue reading »HCV and Cirrhosis
Treatment of HCV in Cirrhotic Patients By Marina Nunez, MD, PhD Hepatitis C virus (HCV) infection is considered difficult to... View Article
Continue reading »
